who suspends un supply of covaxin; no impact on efficacy: bharat biotech
Published 2 years ago • 4.2K plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
1:58
who suspends un supply of bharat biotech's covaxin citing gmp deficiencies
-
16:44
no doubts on safety, efficacy: who chief scientist on covaxin suspension
-
0:43
who suspends un supply of covaxin citing 'deficiencies', calls for bb's facility upgradation
-
0:52
covaxin supply suspended internationally as who finds deficiencies in inspection
-
10:26
covid-19 vaccine: bharat biotech releases covaxin's phase 3 trial data, claims 77.8% efficacy
-
3:46
boeing faces potential strike as workers vote on new contract
-
4:46
war of words between indian vaccine-makers sii & bharat biotech, then truce
-
2:32
covid update: covaxin phase 3 trial; china locks down hebei; uk vaccine supply
-
2:42
covaxin shows interim efficacy of 81% in phase 3 results: bharat biotech
-
3:21
brazil contradicts bharat biotech claim on emergency approval for covaxin
-
1:39
who suspends covaxin’s un supply after eul inspection, the vaccine still effective |oneindia news
-
5:47
bharat biotech's vaccine cleared by expert panel
-
3:33
covid-19 news: bharat biotech says 'no wrongdoing' amid row over brazil covaxin deal
-
18:43
covaxin 81% effective, says bharat biotech and other top stories | the news
-
1:19
who suspends supply of bharat biotech's covaxin vaccine
-
23:29
left, right & centre | vaccine nationalism: bharat biotech slams critics
-
27:27
reality check | covaxin or covishield? the vaccine divide
-
3:04
covid-19 vaccine: who shouldn't take covaxin shot? bharat biotech explains amid concerns
-
2:38
mystery of 'missing' covaxin | reality check
-
5:24
no data on effectiveness, yet covaxin cleared
-
2:54
bharat biotech releases covaxin's price ahead of india's phase 3 of vaccination | covid-19 vaccine
-
3:40
covid-19 news: 70-80% decline in participants for phase3 trial of bharat biotech's covaxin